Home
News
Create
Screeners
Insights
JHS Svendgaard Laboratories
8.
85
-0.15
(-1.67%)
Market Cap
₹75.76 Cr
PE Ratio
-14.59
Industry
Consumer Goods
Buy
Sell
Company Performance:
1D
-1.67%
1M
+27.71%
6M
-31.18%
1Y
-36.74%
5Y
-55.84%
View Company Insights
Latest news about JHS Svendgaard Laboratories
JHS Svendgaard Laboratories Submits Q4FY26 SEBI Compliance Certificate for Dematerialization
Apr 15, 2026
JHS Svendgaard Laboratories Limited filed its Q4FY26 compliance certificate under SEBI Regulation 74(5) on April 15, 2026, covering dematerialization activities for the quarter ended March 31, 2026. The company's registrar agents Alankit Assignments Limited and Beetal Financial & Computer Services provided separate confirmations for different periods within the quarter, verifying proper compliance with dematerialization procedures and regulatory requirements.
JHS Svendgaard Laboratories Announces Change of Registrar & Share Transfer Agent
Apr 15, 2026
Lambodhara Textiles Limited Supports IEPF Authority's Second 100 Days Campaign for Shareholder Benefits
Apr 14, 2026
JHS Svendgaard Laboratories Opens Special Window for Physical Share Transfer Re-lodgement
Apr 01, 2026
JHS Svendgaard Laboratories Reports No Deviation in Fund Utilization for Q3FY26
Feb 10, 2026
More news about JHS Svendgaard Laboratories
01
Feb 26
JHS Svendgaard Laboratories Completes Warrant Conversion, Allots 18.02 Lakh Equity Shares
JHS Svendgaard Laboratories Limited completed the conversion of 18,01,801 warrants into equity shares at Rs. 27.75 per share on February 01, 2026. Coeus Global Opportunities Fund received the entire allocation, paying Rs. 3,74,99,983.31 as the balance amount and acquiring a 2.06% stake in the company. The conversion increased the company's paid-up equity share capital to Rs. 87,40,57,670, comprising 8,74,05,767 equity shares of Rs. 10.00 face value each.
14
Nov 25
JHS Svendgaard Laboratories Approves 31.30 Lakh Employee Stock Options Under New ESOP Scheme
JHS Svendgaard Laboratories Limited has approved the grant of 31,30,000 employee stock options (ESOPs) under its new Employee Stock Option Scheme-2025. The options have a face value and exercise price of Rs. 10 each, with a grant date of November 14, 2025. The vesting period starts one year from the grant date and extends up to five years, with a maximum exercise period of 5 years from each vesting date. The scheme complies with SEBI regulations and aims to align employee interests with company performance.
22
Sept 25
JHS Svendgaard Laboratories Reappoints Nikhil Nanda as Managing Director, Approves Key Appointments
JHS Svendgaard Laboratories Limited held its 21st AGM on September 20, 2025, making several important decisions. Shareholders approved the reappointment of Nikhil Nanda as Managing Director for a five-year term starting July 2, 2025. The company appointed M/s V.K. Khosla & Co as Statutory Auditors and M/s Dahiya & Associates as Secretarial Auditors, both for five-year terms. Mr. Vinay Mittal was appointed as a Director. The JHS Svendgaard Laboratories Limited - Employee Stock Option Scheme 2025 was also approved. Key resolutions, including financial statement adoption, passed with over 99% votes in favor.
JHS Svendgaard Laboratories
8.
85
-
0.
15
(-
1.
67
%)
1 Year Returns:
-36.74%
Industry Peers
Godrej Consumer Products
1,067.10
(-
2.
11
%)
Dabur India
441.50
(-
3.
18
%)
Colgate Palmolive
2,096.20
(-
1.
70
%)
P&G Hygiene and Health Care
10,146.50
(-
2.
16
%)
Gillette
7,953.50
(-
1.
39
%)
Emami
444.50
(-
2.
93
%)
Cupid
119.58
(+
3.
23
%)
Mamaearth
340.60
(-
1.
60
%)
Bajaj Consumer Care
450.45
(-
2.
36
%)
Anondita Medicare
999.20
(-
2.
07
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO